| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 04/22/2004 | US20040077896 Compounds for the treatment of metabolic disorders |
| 04/22/2004 | US20040077649 Novel cannabimimetic ligands |
| 04/22/2004 | US20040077639 Administering amidine derivative as antiasthmatic agents; chronic obstructive pulmonary disease treatment |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1409024A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules |
| 04/21/2004 | CN1146552C Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
| 04/21/2004 | CN1146536C Cycloethylene derivatives |
| 04/20/2004 | US6723798 Combinatorial chemistry; hydroxyphenylalkyl vinyl ether linking group to divinylbenzene-styrene polymer |
| 04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 04/15/2004 | WO2004031139A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/15/2004 | WO2004031137A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 04/15/2004 | WO2004020445A3 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 04/15/2004 | WO2004014317A3 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 04/15/2004 | WO2003083063A3 Common ligand mimics: naphtoates |
| 04/15/2004 | US20040073025 Thrombin inhibitors |
| 04/15/2004 | US20040072886 Cardiovascular disorders; hypotensive agents |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072843 Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 04/15/2004 | DE10195974T5 Neue substituierte Calix-(4)-Pyrrole und Verfahren für die Synthese der Calix-(4)-Pyrrole über Molekularsiebkatalysatoren New substituted calix (4) pyrroles and procedures for the synthesis of calix (4) pyrroles over molecular sieve catalysts |
| 04/15/2004 | CA2500969A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/13/2004 | US6719958 Polychelants, their complexes with metal ions, their preparation and their uses |
| 04/08/2004 | US20040067924 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | EP0946525B1 Method for producing metal complex carboxylic acid amides |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/06/2004 | CA2190992C Naphthalene derivatives |
| 04/01/2004 | WO2004026847A1 Process for the manufacture of valsartan |
| 04/01/2004 | WO2004006934A3 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours |
| 04/01/2004 | US20040063685 Cycloalkene antisepsis drug with antibacterial, antifungal, nonsteroidal antiinflammatory, steroid and/or anticoagulant agents |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | CA2502629A1 Process for the manufacture of valsartan |
| 03/31/2004 | CN1143853C Preparing method for anti-viral compounds |
| 03/30/2004 | US6713507 Ether compounds and compositions for cholesterol management and related uses |
| 03/30/2004 | CA2305933C (poly)thia-alcynoic compounds and their derivatives, compositions containing them and their uses |
| 03/25/2004 | WO2003074523A3 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates |
| 03/25/2004 | WO2003027081A3 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 03/24/2004 | EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | EP1003505B1 Heterocyclic vinylethers against neurological disorders |
| 03/24/2004 | CN1142918C Carboxylic acid derivs, their preparation and their use |
| 03/23/2004 | US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022525A1 Amide derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004021996A2 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 03/18/2004 | WO2004012733A3 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/18/2004 | WO2003086563A3 Diabetes imaging probes |
| 03/18/2004 | US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | CA2495442A1 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 03/18/2004 | CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers |
| 03/17/2004 | EP1398027A1 Use of matrix metalloproteinase inhibitors for treating or preventing glomerulopathy |
| 03/17/2004 | CN1482120A Process for preparing S,Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound |
| 03/16/2004 | US6706749 Substituted phenyl derivatives, their preparation and use |
| 03/16/2004 | US6706744 Hypoglycemic agents; antidiabetic agents |
| 03/11/2004 | WO2004020445A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 03/11/2004 | WO2004020393A1 Dibenzylamine compound and medicinal use thereof |
| 03/11/2004 | WO2004002462A3 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
| 03/11/2004 | WO2003082861A3 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases |
| 03/11/2004 | WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | US20040048909 N-alkyl-N-(p-substituted-phenyl)benzylamine that is N-substituted with carbocyclic aminocarbonylalkylene, aminocarbonyl, or aminocarbonylaminosulfonyl; ACAT inhibitors; treating e.g.,hypercholesterolemia and atherosclerosis |
| 03/11/2004 | US20040048863 Treating osteoarthritis or rheumatoid arthritis |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | CN1481371A Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethy-l,4,7,10-tetraazacyclododecane, prodn. and use thereof |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/04/2004 | WO2004018461A2 Antibacterial benzoic acid derivatives |
| 03/04/2004 | WO2004018386A2 Acetophenone potentiators of metabotropic glutamate receptors |
| 03/04/2004 | CA2495756A1 Acetophenone potentiators of metabotropic glutamate receptors |
| 03/03/2004 | EP1392660A1 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |
| 03/03/2004 | EP1392315A1 Methods of treating alzheimer's disease |
| 03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
| 03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims |
| 03/02/2004 | US6699893 Glucocorticoid receptor modulators |
| 03/02/2004 | US6699878 Imidazonaphthyridines |
| 02/26/2004 | WO2003074008A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 02/26/2004 | WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 02/26/2004 | US20040039229 Method for recovery of nitramines from aluminized energetic materials |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/24/2004 | US6696475 Substituted phenyl derivatives, their preparation and use |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/19/2004 | WO2004014366A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014317A2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 02/19/2004 | WO2004014316A2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 02/19/2004 | US20040034072 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/19/2004 | US20040034069 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 02/19/2004 | US20040034034 Novel piperazine derivatives |
| 02/19/2004 | US20040033995 Nitrogen compounds, stereoisomers and/or racemic mixtures used as enzyme inhibitors for prophylaxis of inflammatory diseases |
| 02/19/2004 | CA2495266A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 02/19/2004 | CA2495245A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 02/18/2004 | EP1389191A1 Heterocyclyl phenyl benzyl ethers used as fungicides |
| 02/18/2004 | EP1389185A2 Aminoalcohol derivatives |
| 02/18/2004 | EP1389183A1 Sulfonamide derivatives |
| 02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
| 02/17/2004 | US6693190 Tetraazacyclododecane macrocycle derivatives including metal complexes; magnetic resonance imaging agents |